Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy

Journal of Infectious Diseases

Volumn 183, Issue 1, 2001, Pages 36-50

  Imamichi, Hiromi ^a   Crandall, Keith A ^c   Natarajan, Ven ^a   Jiang, Min Kang ^a   Dewar, Robin L ^a   Berg, Steve ^a   Gaddam, Arunasri ^a   Bosche, Marjorie ^a   Metcalf, Julia A ^b   Davey, R T ^b   Lane, H Clifford ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REBOUND; VIREMIA; VIRION; VIRUS LATENCY; VIRUS REPLICATION;

ADULT; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROVIRUSES; RECURRENCE; RNA, VIRAL; SEQUENCE ALIGNMENT; VIRAL LOAD; VIRION; VIRUS REPLICATION;

EID: 0035173896     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317641     Document Type: Article

References (35)

1. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
2. A controlled trial of two nucleotide analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
4. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
5. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
6. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
7. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
8. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
9. HIV-1 replication in patients with undetectable plasma virus receiving HAART
10. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent anti-retroviral therapy
11. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
12. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type-1 infected individuals on prolonged effective antiretroviral therapy
13. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
14. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
15. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
16. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment
17. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma
18. Isolation and detection of human immunodeficiency virus
19. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy
20. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its gag substrate cleavage sites
21. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties, and weight matrix choice
22. Multiple aligned sequence editor (MASE)
23. PAUP*: Phylogenetic analysis using parsimony and other methods, version 4.0.0b2
24. The neighbor-joining method: A new method for reconstructing phylogenetic trees
25. MODELTEST: Testing the model of DNA substitution
26. Estimation of evolutionary distances between homologous nucleotide sequences
27. Dating the human-ape splitting by a molecular clock of mitochondrial DNA
28. Confidence limits on phylogenies: An approach using the bootstrap
29. Evaluation of the maximum likelihood estimate of the evolutionary tree topologies from DNA sequence data, and the branching order in Hominoidea
30. Signature pattern analysis: A method for assessing viral sequence relatedness
31. Quantitation of latent tissue reservoirs and total body load in HIV-1 infection
32. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
33. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease
34. The role of mononuclear phagocytes in HTLV-III/LAV infection
35. Multiple modes of cellular activation and virus transmission in HIV infection: A role of chronically and latently infected cells in sustaining viral replication